Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3954962
Max Phase: Preclinical
Molecular Formula: C38H51F3N8O8
Molecular Weight: 804.87
Molecule Type: Small molecule
Associated Items:
ID: ALA3954962
Max Phase: Preclinical
Molecular Formula: C38H51F3N8O8
Molecular Weight: 804.87
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C=CC(=O)NC[C@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(=O)N1C[C@@H]2CCC[C@@H]2[C@H]1C(=O)N[C@@H](CCC)C(OC(=O)C(F)(F)F)C(=O)NC1CC1
Standard InChI: InChI=1S/C38H51F3N8O8/c1-3-9-25(31(35(54)45-23-14-15-23)57-37(56)38(39,40)41)46-34(53)30-24-13-8-12-22(24)20-49(30)36(55)27(19-44-28(50)4-2)47-33(52)29(21-10-6-5-7-11-21)48-32(51)26-18-42-16-17-43-26/h4,16-18,21-25,27,29-31H,2-3,5-15,19-20H2,1H3,(H,44,50)(H,45,54)(H,46,53)(H,47,52)(H,48,51)/t22-,24-,25-,27-,29-,30-,31?/m0/s1
Standard InChI Key: UABMAUQOFZTIIT-QQWMEIISSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 804.87 | Molecular Weight (Monoisotopic): 804.3782 | AlogP: 1.61 | #Rotatable Bonds: 17 |
Polar Surface Area: 217.89 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 16 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.84 | CX Basic pKa: 0.30 | CX LogP: 1.39 | CX LogD: 1.39 |
Aromatic Rings: 1 | Heavy Atoms: 57 | QED Weighted: 0.11 | Np Likeness Score: -0.23 |
1. (2016) HCV protease inhibitors and uses thereof, |
Source(1):